Press Room

Webinar - Accessing Continuous Tableting Through a CDMO

Start
Wednesday, October 11, 2023 - 16:00
Location: online

October 11, 2023

11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

 

Available on-demand

 

Featured Hovione experts in this webinar
Hovione_Sarang Oka
Sarang Oka

Production Senior Manager
Drug Product Continuous Manufacturing

 

The webinar, focused on Continuous Tableting of oral solid dosage forms, also known as Continuous Tableting (CT), will introduce the concept of working with a CDMO to develop and launch a CT-based program. The discussion will focus on the business case for Continuous Tableting in the context of working with a CDMO.

 

Intrinsic technology-driven advantages such as higher product quality, greater supply chain flexibility, opportunity to accelerate time-to-market and ability to implement advanced process control as well as those that manifest from working with an experienced CDMO will be shared.

 

Key Learning Objectives: 

  • Learn about important considerations when implementing Continuous Tableting – advantages and challenges.
  • Understand the advantages of working with a CDMO for a Continuous Tableting based program. This includes new products as well as batch to continuous conversions.
  • Case studies will be presented showing how big data sets generated in Continuous Tableting enable the implementation of process improvements.

Who Should Attend

  • Individuals and organizations who are curious to learn about technology, its fundamental benefits and challenges.
  • Current and aspiring practitioners of the technology who are interested about the implementation of Continuous Tableting at a CDMO.

 

Available on-demand

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025